Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Involving family members in care may reduce hospital readmissions

A new study finds that educating and involving family members in the care of a loved one who has memory loss may significantly reduce hospital readmissions.

28 Jan 2016

New diagnostic method shows COPD risk higher for women

Researchers from Lund University Sweden have through a new diagnostic method been able to show that the risk of developing Chronic Obstructive Pulmonary Disease could be twice as high for women as it is for men.

19 Jan 2016

GBI Research says COPD therapeutics pipeline lacks innovation

Analysis from business intelligence provider GBI Research - Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation - states that while currently-available drugs aim to manage the frequency and severity of symptoms associated with COPD, none have been shown to modify long-term disease progression.

19 Jan 2016

Specialized oral nutrition supplement associated with 50% lower death rate in older patients

Results from a new clinical trial show that a specialized oral nutrition supplement was associated with a 50 percent lower death rate in older malnourished patients with a heart or lung disease 90 days following hospitalization.

18 Jan 2016

Alignment Healthcare, HCA West Florida partner to better serve Medicare beneficiaries in West Florida

Alignment Healthcare, a company focused on improving the health of the Medicare population, announced that it has joined forces with HCA West Florida to better serve Medicare beneficiaries in three West Florida counties: Manatee, Pinellas and Sarasota.

13 Jan 2016

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

Malaysian scientists are joining forces with Harvard University experts to help revolutionize the treatment of lung diseases -- the delivery of nanomedicine deep into places otherwise impossible to reach.

12 Jan 2016

Qualcomm Life expands global connected therapy management collaboration with Novartis

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.

6 Jan 2016

Body can control pathogen-induced inflammatory response, find Georgia State researchers

The body can control inflammatory response triggered by invasions of microbial pathogens, such as bacteria and viruses, a discovery that could lead to the development of new therapeutic agents for uncontrolled inflammation, according to researchers at Georgia State University.

29 Dec 2015

Music therapy in conjunction with standard rehabilitation benefits COPD patients

Patients with Chronic Obstructive Pulmonary Disease (COPD) and other chronic respiratory disorders who received music therapy in conjunction with standard rehabilitation saw an improvement in symptoms, psychological well-being and quality of life compared to patients receiving rehabilitation alone, according to a new study by researchers at The Louis Armstrong Center of Music and Medicine at Mount Sinai Beth Israel (MSBI).

24 Dec 2015

Small airway-on-a-chip enables analysis of human COPD and asthma

A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.

22 Dec 2015

IQWiG examines added benefit of tiotropium and olodaterol combination in adults with COPD

The fixed-dose combination of tiotropium and olodaterol (trade name: Spiolto Respimat) has been approved since July 2015 for maintenance treatment in adults with chronic obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug combination offers an added benefit over the appropriate comparator therapy.

22 Nov 2015

Study finds high prevalence of dehydration in older people living in UK care homes

One in every five older people living in UK care homes has dehydration, suggesting that they are not drinking enough to keep themselves healthy.

11 Nov 2015

Rheumatoid arthritis significantly increases risk of death due to cardiovascular causes

Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.

3 Nov 2015

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.

30 Oct 2015

New studies analyse life expectancy, causes of death and child mortality in different regions of China

Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades.

28 Oct 2015

Common heartburn, acid reflux drugs may increase risk for developing kidney disease

Certain medications commonly used to treat heartburn and acid reflux may have damaging effects on the kidneys, according to two studies that will be presented at ASN Kidney Week 2015 November 3–8 at the San Diego Convention Center in San Diego, CA. The drugs, proton pump inhibitors (PPIs), are among the top 10 class of prescribed medications in the United States.

28 Oct 2015

Drug that relieves opioid-induced constipation may help some cancer patients live longer

Patients with advanced cancers who took a drug designed to relieve constipation caused by pain killers lived longer and had fewer reports of tumor progression than cancer patients who did not receive the drug, according to results presented October 27 at the 2015 meeting of the American Society of Anesthesiologists in San Diego. This is the first study in humans to associate opioid blockade with improved survival.

28 Oct 2015

Study finds overall decreasing trend in leading causes of death

An analysis of deaths in the United States between 1969 and 2013 finds an overall decreasing trend in the age-standardized death rate for all causes combined and for heart disease, cancer, stroke, unintentional injuries, and diabetes, although the rate of decrease appears to have slowed for heart disease, stroke, and diabetes, according to a study in the October 27 issue of JAMA.

28 Oct 2015

Localisation of policies crucial to China's health reforms, new studies suggest

Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades. The articles analyse life expectancy, causes of death, and child mortality for 31 provinces, municipalities, autonomous regions of China, and Hongkong and Macao special administrative regions, finding that in the last two decades, life expectancy has risen, and deaths in children under 5 years have fallen, in every province.

26 Oct 2015

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Henry Ford Hospital pulmonologist Daniel Ouellette, M.D., who during his 31-year career in medicine has seen the harmful effects of smoking on his patients, advocates for raising the smoking age to 21.

22 Oct 2015

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Involving family members in care may reduce hospital readmissions

New diagnostic method shows COPD risk higher for women

GBI Research says COPD therapeutics pipeline lacks innovation

Specialized oral nutrition supplement associated with 50% lower death rate in older patients

Alignment Healthcare, HCA West Florida partner to better serve Medicare beneficiaries in West Florida

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

Qualcomm Life expands global connected therapy management collaboration with Novartis

Body can control pathogen-induced inflammatory response, find Georgia State researchers

Music therapy in conjunction with standard rehabilitation benefits COPD patients

Small airway-on-a-chip enables analysis of human COPD and asthma

IQWiG examines added benefit of tiotropium and olodaterol combination in adults with COPD

Study finds high prevalence of dehydration in older people living in UK care homes

Rheumatoid arthritis significantly increases risk of death due to cardiovascular causes

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

New studies analyse life expectancy, causes of death and child mortality in different regions of China

Common heartburn, acid reflux drugs may increase risk for developing kidney disease

Drug that relieves opioid-induced constipation may help some cancer patients live longer

Study finds overall decreasing trend in leading causes of death

Localisation of policies crucial to China's health reforms, new studies suggest

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in